Related Experiment Videos
Interferon-alpha reduces the development of experimental necrotizing enterocolitis.
Sema Uguralp1, Bulent Mizrak, Aysun Bay Karabulut
1Department of Pediatric Surgery, Turgut Ozal Medical Center, Inonu University, Faculty of Medicine, 44069 Malatya, Turkey. suguralp@inonu.edu.tr
Cytokine
|March 24, 2004
Summary
Interferon-alpha (IFN-alpha) demonstrated a protective effect against experimental necrotizing enterocolitis (NEC) in newborn rats. This cytokine therapy significantly reduced intestinal injury and malondialdehyde levels, suggesting a potential prophylactic role in NEC prevention.
Area of Science:
- Neonatal research
- Gastroenterology
- Immunology
Background:
- Cytokines play a crucial role in the pathogenesis of necrotizing enterocolitis (NEC), a serious intestinal condition in newborns.
- Investigating novel therapeutic agents is essential for managing and preventing NEC.
Purpose of the Study:
- To evaluate the prophylactic efficacy of interferon-alpha (IFN-alpha) in an experimental model of NEC in newborn rat pups.
- To assess the impact of IFN-alpha on histological damage and biochemical markers of intestinal injury.
Main Methods:
- Twenty-eight Wistar Albino newborn rat pups were divided into control, NEC, and IFN-alpha treated groups.
- NEC was induced via cold stress, and IFN-alpha was administered subcutaneously.
- Intestinal tissue was analyzed for malondialdehyde (MDA) levels and histological changes.
Main Results:
- The NEC group exhibited severe intestinal lesions, including villous loss and necrosis, with significantly elevated MDA levels.
- IFN-alpha treatment resulted in moderate lesions and significantly lower MDA levels compared to the NEC group.
- Histological injury scores were significantly reduced in the IFN-alpha treated group (P<0.05).
Conclusions:
- IFN-alpha was effective in reducing the severity of experimental NEC in rat pups.
- The findings suggest that IFN-alpha may hold potential as a prophylactic agent for NEC.